Sriboonaied, P.; Phuangbubpha, P.; Saetan, P.; Charoensuksai, P.; Charoenpanich, A.
Dual Modulation of Adipogenesis and Apoptosis by PPARG Agonist Rosiglitazone and Antagonist Betulinic Acid in 3T3-L1 Cells. Biomedicines 2025, 13, 1340.
https://doi.org/10.3390/biomedicines13061340
AMA Style
Sriboonaied P, Phuangbubpha P, Saetan P, Charoensuksai P, Charoenpanich A.
Dual Modulation of Adipogenesis and Apoptosis by PPARG Agonist Rosiglitazone and Antagonist Betulinic Acid in 3T3-L1 Cells. Biomedicines. 2025; 13(6):1340.
https://doi.org/10.3390/biomedicines13061340
Chicago/Turabian Style
Sriboonaied, Patsawee, Pornwipa Phuangbubpha, Puretat Saetan, Purin Charoensuksai, and Adisri Charoenpanich.
2025. "Dual Modulation of Adipogenesis and Apoptosis by PPARG Agonist Rosiglitazone and Antagonist Betulinic Acid in 3T3-L1 Cells" Biomedicines 13, no. 6: 1340.
https://doi.org/10.3390/biomedicines13061340
APA Style
Sriboonaied, P., Phuangbubpha, P., Saetan, P., Charoensuksai, P., & Charoenpanich, A.
(2025). Dual Modulation of Adipogenesis and Apoptosis by PPARG Agonist Rosiglitazone and Antagonist Betulinic Acid in 3T3-L1 Cells. Biomedicines, 13(6), 1340.
https://doi.org/10.3390/biomedicines13061340